We recently published a list of 8 Most Promising Healthcare Stocks According to Hedge Funds. In this article, we are going to ...

In clinical trials, most participants taking Wegovy or Mounjaro to treat obesity lost an average of 15% to 22% of their body ...

First Amendment: Congress shall make no law respecting an establishment of religion, or prohibiting the free exercise thereof; or abridging the freedom of speech, or of the press; or the right of the ...

America's kitchen trash bins are receiving more unwanted food as appetites falter among people taking GLP-1 weight-loss meds, ...

America's kitchen trash bins are receiving more unwanted food as appetites falter among people taking GLP-1 weight-loss meds, ...

As GLP-1 medications like Ozempic soar in popularity, our new documentary follows three people on their weight-loss journeys — and explores how decades of diet culture paved the way for the drugs’ ...

Zepbound, a drug used to help patients lose weight and manage diabetes, may also help those with heart failure, a new trial ...

From there, the case for or against investing in Lilly should become much clearer. Eli Lilly's earnings report ...

Upcoming data from a mid-stage study of Amgen's experimental weight-loss drug MariTide will shed light on how well it might ...

A drug used to help patients lose weight and manage diabetes may also help those with heart failure, an internationa ...

A survey by consulting firm Mercer shows that close to half of U.S. companies with more than 500 employees now cover drugs ...

Drug manufacturers are racing to develop an oral version of popular weight loss injectables like Ozempic, and early studies ...